David McIntyre, Chief Financial Officer at Avita Therapeutics, Inc. (RCEL), bought 693 shares at $23.85 ($16K) on 2020-07-16, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.85 | 300 | $7K | 44.5% |
| 2 | $22.70 | 393 | $9K | 55.5% |
| Total | $23.20 avg | 693 | $16K | 100% |
| Filing → |
| HTWR | SELL | 2011-02-24 | $251K | — | Filing → |
| HTWR | SELL | 2010-09-20 | $1.7M | — | Filing → |
| HTWR | SELL | 2010-04-30 | $1.1M | — | Filing → |